Загрузка...
The discovery and development of belimumab: the anti-BLyS–lupus connection
For the first time in more than 50 years, the US Food and Drug Administration has approved a drug specifically for the treatment of systemic lupus erythematosus (SLE). This drug, belimumab (Benlysta), is a human monoclonal antibody that neutralizes the B-cell survival factor, B-lymphocyte stimulator...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3264947/ https://ncbi.nlm.nih.gov/pubmed/22231104 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nbt.2076 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|